| [1] | Wenjing NI, Nan GENG, Xue BAI, Jie LI. An excerpt of EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease in 2024[J]. Journal of Clinical Hepatology, 2024, 40(8): 1567-1574. doi: 10.12449/JCH240810 |
| [2] | Manman XU, Nan GENG, Yu CHEN. An excerpt of EASL clinical practice guidelines on acute－on－chronic liver failure （2023）[J]. Journal of Clinical Hepatology, 2023, 39(10): 2321-2327. doi: 10.3969/j.issn.1001-5256.2023.10.008 |
| [3] | Huimin LIU, Wenting CHEN, Shilian LI, Hongmei GONG, Qing. MAO. Key points of EASL Clinical Practice Guidelines on hepatitis delta virus （2023）[J]. Journal of Clinical Hepatology, 2023, 39(11): 2558-2563. doi: 10.3969/j.issn.1001-5256.2023.11.007 |
| [4] | Dandan JIA, Guiying ZHU, Shiyao LIAO, Hui ZHANG, Hui GUO, Lili YANG, Changmiao WANG. Interpretation of European Society for Clinical Nutrition and Metabolism practical guideline : Clinical nutrition in liver disease (2020)[J]. Journal of Clinical Hepatology, 2021, 37(7): 1553-1557. doi: 10.3969/j.issn.1001-5256.2021.07.015 |
| [5] | YANG Jia, RAO HuiYing. EASL recommendations on treatment of hepatitis C: Final update of the series (2020)[J]. Journal of Clinical Hepatology, 2020, 36(12): 2681-2687. doi: 10.3969/j.issn.1001-5256.2020.12.009 |
| [6] | Yu LeCheng, Lai RongTao, Chen ChengWei. Key points and interpretation of EASL clinical practice guidelines: Drug-induced liver injury (2019)[J]. Journal of Clinical Hepatology, 2019, 35(6): 1242-1250. doi: 10.3969/j.issn.1001-5256.2019.06.013 |
| [7] | Zhou YiXia, Gao Ya, Li Wu. An excerpt of EASL Clinical Practice Guidelines on nutrition in chronic liver disease (2018)[J]. Journal of Clinical Hepatology, 2018, 34(11): 2305-2310. doi: 10.3969/j.issn.1001-5256.2018.11.008 |
| [8] | Yang Jia, Rao HuiYing, Wei Lai. Introduction and interpretation of EASL recommendations on treatment of hepatitis C 2018[J]. Journal of Clinical Hepatology, 2018, 34(8): 1622-1631. doi: 10.3969/j.issn.1001-5256.2018.08.007 |
| [9] | Song Yang, Zhou Fei, Chen LiGang. An excerpt of EASL clinical practice guidelines: Management of alcohol-related liver disease (2018)[J]. Journal of Clinical Hepatology, 2018, 34(7): 1415-1419. doi: 10.3969/j.issn.1001-5256.2018.07.010 |
| [10] | Ge NingLing, Xue TongChun, Ye ShengLong. Interpretation of EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (2018)[J]. Journal of Clinical Hepatology, 2018, 34(6): 1187-1190. doi: 10.3969/j.issn.1001-5256.2018.06.011 |
| [11] | Yu JiongJie, Yan WenTao, Quan Bing, Yang Tian. Recommendations for EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (2018)[J]. Journal of Clinical Hepatology, 2018, 34(6): 1183-1186. doi: 10.3969/j.issn.1001-5256.2018.06.010 |
| [12] | Li Yan, Tang ShanHong. An excerpt of EASL clinical practice guidelines on hepatitis E virus infection 2018[J]. Journal of Clinical Hepatology, 2018, 34(7): 1410-1414. doi: 10.3969/j.issn.1001-5256.2018.07.009 |
| [13] | Yu LeCheng, Hou JinLin. The highlights of EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2017, 33(6): 1017-1032. doi: 10.3969/j.issn.1001-5256.2017.06.002 |
| [14] | Yang Min, Zhang ShengGuo, Lu MingQin. EASL clinical practical guidelines on the management of acute(fulminant) liver failure(2017)[J]. Journal of Clinical Hepatology, 2017, 33(10): 1883-1887. doi: 10.3969/j.issn.1001-5256.2017.10.007 |
| [15] | Huang Cheng, Sun HuiChuan. EASL clinical practice guidelines on the management of benign liver tumors (2016)[J]. Journal of Clinical Hepatology, 2016, 32(8): 1439-1445. doi: 10.3969/j.issn.1001-5256.2016.08.001 |
| [16] | Gao Fan, Hu FengRong, Qi XingShun. An excerpt of 2015 EASL clinical practical guidelines: vascular diseases of the liver [J]. Journal of Clinical Hepatology, 2016, 32(1): 40-43. doi: 10.3969/j.issn.1001-5256.2016.01.005 |
| [17] | Shen ShanShan, Dai MingJia, Yan XueBing. Interpretation and analysis of EASL recommendations on treatment of hepatitis C 2016[J]. Journal of Clinical Hepatology, 2016, 32(12): 2258-2262. doi: 10.3969/j.issn.1001-5256.2016.12.006 |
| [19] | Chang BinXia, Li BaoSen, Zou ZhengSheng. An excerpt of EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease(2016)[J]. Journal of Clinical Hepatology, 2016, 32(8): 1450-1454. doi: 10.3969/j.issn.1001-5256.2016.08.003 |
| [20] | Shi YingHong, Tian MengXin, Fan Jia. Recommendations for EASL clinical practice guidelines: liver transplantation（2015）[J]. Journal of Clinical Hepatology, 2016, 32(3): 429-431. doi: 10.3969/j.issn.1001-5256.2016.03.005 |
DownLoad: